Research from Tulane University examines the long-term effects of influenza and coronavirus on the body, revealing significant differences in their impact on the lungs and brain.
Researchers at Tulane University have investigated how long-term effects of influenza and COVID-19 differ using a mouse model. Their findings, published in Frontiers in Immunology, indicate that both influenza and COVID-19 can leave lasting damage to lung tissue, with implications for persistent respiratory issues. The study shows that collagen, a protein related to scarring, accumulates in the lung tissue of both diseases, and immune cells remain active longer than normal, contributing to the stiffening of lung tissue. This stiffness may explain why some individuals experience shortness of breath long after recovery, with potential for permanent lung damage.
Upon further examination, the researchers discovered a key difference between the two diseases. After influenza, the lungs of the mice entered a repair mode, sending out specialized cells to address the damage. In contrast, similar reparative processes were not observed following COVID-19. This suggests that while both diseases can cause significant fibrosis in the lungs, only COVID-19 may have long-lasting effects on brain function. The findings underscore the importance of understanding these differences in managing patient care and rehabilitation following viral infections.
Overall, the study highlights the need for ongoing research into the long-term sequelae of both influenza and COVID-19, particularly as healthcare systems navigate the repercussions of the COVID-19 pandemic. The lingering effects of these viruses not only impact individual health but also bear implications for public health strategies and resource allocation in post-viral care.
